| Tag | Content |
|---|
EnhancerAtlas ID | HS073-09910 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr22:40887610-40889620 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr22:40888170-40888188 | TCTTCCTTCCCTCTCTCC | - | 6.32 | | IRF1 | MA0050.2 | chr22:40889546-40889567 | AAAAGGAAAATGAAAGAGGAA | - | 7.39 | | Sox3 | MA0514.1 | chr22:40889188-40889198 | AAAACAAAGG | - | 6.02 | | ZNF263 | MA0528.1 | chr22:40888170-40888191 | TCTTCCTTCCCTCTCTCCTTA | - | 6.55 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09266 | chr22:40885735-40890500 | CD14 | | SE_46599 | chr22:40887668-40889759 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr22 | 40888200 | 40889540 | | chr22 | 40887675 | 40889002 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I040490 | chr22 | 40886711 | 40890107 |
|
Enhancer Sequence | GCCAAAGTGC ATTTTATGGA TAAAACATTG AATCTGACCC ACATAAAGAG TAATTCCGCC 60
TTATTAAAGA AAAGTTTTTT CTTCCCTTAT TCCACAATCT AGGCTTGGCT ATATGAGCTC 120
TGCACGGTGG GGAAAAAAGG AGTAAGAAAG TGAAACATCC TAATCACTGT TCCACCAGGT 180
CATGAAATGC ACCCTACAGT ACTATGTTCA GTTATCTATT TGTTGGGTGC TCAACAAACT 240
TTAATACAAA TCCTGGGAGA ATAAACCACC CAAAGTCAAA GCTTGGATGG CTACAGAGAA 300
ATAGGACTGG GATAAAAGAC AGCAGTTAAG TTTGAAAGGA AACAAAAGCA TGCAAATCCC 360
AAAGGCACAA ATACTCGAAC CTTCCCGCAA ACTGTGATAA TGGGTCAGGC ACACTGCTGA 420
GTAATAGCTG TCCTTTCTCG GCTTCAGGAC AATCCACGAG AGTGGCAGAA TCCTGCAGGT 480
GGACTGATGA ATCTTGGCCT TCTCCTCCAG CATGCTGGAG GAGATTCGAG TCTCCACAGG 540
CCAATGCTGC AATAAACCAC TCTTCCTTCC CTCTCTCCTT AAAGAGGCCA TTTATTATTT 600
GCCGAAGATC TGATTAGCCC TGCTCTTTAA GTTAAAGTGG GCACTTCATT CTACAGTGCA 660
AAGGGTTGCA AGAACAGTTA GATCCCAAGT TTACTTAGGG AGTGGGGCAT TAAAAGCAGT 720
GACAGCAGAA GGTCAGAATC AGTAACTCTA CTGGCAAAAC ATTTCTTCCT GTCAGCACTG 780
GGCCTAGACA CAGACACCTC CCTCTTCTAT CCAAATGCCA AAAAGCAGAA CTGAGATGAT 840
TTCAATGTGT AGAGCTGGAA GAGGAGAGGG TTCCCTTAGA GAAAATGCTC ATAGCAACCA 900
ACCAACCTCA TTCACCCAAA ATAGTAAACA GTTGGTTTCT CTGCTCAGAA CCAAAAGGCT 960
TCTGCCAGAC AAGCAGTATC ACATGACTAG GTTCCCTCTT CTCTCTCTTG CCCTCCCTCC 1020
CTTCTTGTAC AAAGCCTGCA CCCAAAATGG AACAAGGAGC TATAACACAA CATTATTTTA 1080
CTGGACACAT TCATCTTTAA AATGTTTGAA GATAAAAGAT ACCAAAAAGC AGAGGGGGGA 1140
GGTACCAAAG GAAAAACTCA GGAAGAATTT ACTTTGAAAA AAGTCCTATC ACAGTACTGA 1200
TGTGGGAACC ATAAACGTAA TGGTTAACTG GCAAGTGTAC TCAATGAATG AAAAAACAAA 1260
TGGACACTTC TCACCAATTT GTAAACACTT TGCTGACAAA ATATTTAAAA GAAGATACAG 1320
TTCAATACAT ATTTGACCTT TCCTTTAGAA AGACAATATA GGCTCTTAAG ATGCTGGCTA 1380
GAGTCAGAGA TAATATATTG GCACAATAGT GACAACCCAC CAAAATTTGG GATTCAAACC 1440
CTTATCTTGT TGACCTCAGC TTACCTCACC ATTTGATTTT ACTCCTTGTA TGTCACAGTC 1500
CCATCATTCA CATCATTAGG AAGGAAATCA GGACAGCTAC ACTAACAGGC AACTGAAAAA 1560
TCTACCCAGC TGATTATGAA AACAAAGGCC ACCATGACAC TGGCATTTCC ACCTAAACAG 1620
AAGGGGGAAG ATATTAAGGC TGACAGCACA GCTGGAACCA GATGTGCCAC CATATTCTTC 1680
TCCCTACAAG GTTCCTCACA CTTGAAAGCT AAGCGAGGCA TGCAGTATAG AGACACAAAA 1740
ATGAAAACCT CTATGCTGAT CAATCTGTTC CACTAGGAAA CTAGATAAAG TATAAGAATC 1800
AAAAGTGTCA CAATCATCTG CCATGACCTC TACTCACAGG GCCAACAGGG GCACTTTGAG 1860
AGTAAAATCA CTGATGCTCG TCCATCCCTT GCACTGTAAA CTGCTCAATA AATATTTATA 1920
AAGTGGAAAG AAAAGGAAAA GGAAAATGAA AGAGGAAAAA TTTACATGAG AAATCCTTAA 1980
TTTAAGCAAC AATTTTTCCA GCAAGAGCAT 2010
|
